IRVINE, Calif., Oct. 16, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present
PITTSBURGH, PA, October 15, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing therapies for serious diseases
KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates New York, NY, October 15, 2024 – PRISM
NEW YORK, October 14, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of
PITTSBURGH, Oct. 09, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious
London, October 5, 2024 – PRISM MediaWire – We are pleased to share an exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy,
Londres, October 5, 2024 – PRISM MediaWire – Nos complace compartir una entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación
London, October 5, 2024 – PRISM MediaWire – Temos o prazer de compartilhar uma entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia,
Strategic head-to-head study of BR-AC vs. standard of care aims to demonstrate healing superiority potential to support increased payor coverage and market growth The study
NEWPORT BEACH, CA, October 2, 2024 – PRISM MediaWire – Neon Bloom, Inc. (OTC PINK: NBCO)announced today that it has finalized a business relationship with
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
